Kunisaki C - Search Results

1

Prognostic Impact of Serum SCC Antigen in the 566 Upfront Surgery Group of Esophageal Squamous Cell Carcinoma: A Multi-Institutional Study of the Japan Esophageal Society.

Suzuki T, Yajima S, Okamura A, Yoshida N, Taniyama Y, Murakami K, Ohkura Y, Nakajima Y, Yagi K, Fukuda T, Ogawa R, Hoshino I, Kunisaki C, Narumiya K, Tsubosa Y, Yamada K, Shimada H. Suzuki T, et al. Among authors: kunisaki c. Ann Thorac Cardiovasc Surg. 2024;30(1):24-00028. doi: 10.5761/atcs.oa.24-00028. Ann Thorac Cardiovasc Surg. 2024. PMID: 38583987 Free PMC article.

2

Significance of para-aortic lymph node dissection in advanced gastric cancer.

Kunisaki C, Shimada H, Yamaoka H, Wakasugi J, Takahashi M, Akiyama H, Nomura M, Moriwaki Y. Kunisaki C, et al. Hepatogastroenterology. 1999 Jul-Aug;46(28):2635-42. Hepatogastroenterology. 1999. PMID: 10522056

3

[Factor V inhibitor developed after the surgery of esophageal cancer].

Okita M, Kunisaki C, Kurosawa N, Motizuki Y, Shinohara K, Negishi Y, Yamaguti S, Shimada H, Watanabe S. Okita M, et al. Among authors: kunisaki c. Nihon Shokakibyo Gakkai Zasshi. 2000 Mar;97(3):327-30. Nihon Shokakibyo Gakkai Zasshi. 2000. PMID: 10741157 Japanese. No abstract available.

4

Indications for paraaortic lymph node dissection in gastric cancer patients with paraaortic lymph node involvement.

Kunisaki C, Shimada H, Yamaoka H, Takahashi M, Ookubo K, Akiyama H, Nomura M, Moriwaki Y. Kunisaki C, et al. Hepatogastroenterology. 2000 Mar-Apr;47(32):586-9. Hepatogastroenterology. 2000. PMID: 10791244

5

Appropriate lymph node dissection for early gastric cancer based on lymph node metastases.

Kunisaki C, Shimada H, Nomura M, Akiyama H. Kunisaki C, et al. Surgery. 2001 Feb;129(2):153-7. doi: 10.1067/msy.2001.110222. Surgery. 2001. PMID: 11174707

6

Prognostic factors in early gastric cancer.

Kunisaki C, Shimada H, Takahashi M, Ookubo K, Moriwaki Y, Akiyama H, Nomura M. Kunisaki C, et al. Hepatogastroenterology. 2001 Jan-Feb;48(37):294-8. Hepatogastroenterology. 2001. PMID: 11268989

7

Progressive improvement of prognosis for patients with gastric cancer (dynamic stage grouping) with increasing survival interval from initial staging: how much longer can a given survivor expect to live?

Moriwaki Y, Kunisaki C, Kobayashi S, Harada H, Imai S, Kido Y, Kasaoka C. Moriwaki Y, et al. Among authors: kunisaki c. Surgery. 2003 Feb;133(2):135-40. doi: 10.1067/msy.2003.95. Surgery. 2003. PMID: 12605173

8

Prognostic factors in esophageal cancer.

Kunisaki C, Shimada H, Akiyama H, Nomura M, Matsuda G, Ono H. Kunisaki C, et al. Hepatogastroenterology. 2004 May-Jun;51(57):736-40. Hepatogastroenterology. 2004. PMID: 15143904

9

Therapeutic strategy for signet ring cell carcinoma of the stomach.

Kunisaki C, Shimada H, Nomura M, Matsuda G, Otsuka Y, Akiyama H. Kunisaki C, et al. Br J Surg. 2004 Oct;91(10):1319-24. doi: 10.1002/bjs.4637. Br J Surg. 2004. PMID: 15376179

10

Surgical outcomes for early gastric cancer in the upper third of the stomach.

Kunisaki C, Akiyama H, Nomura M, Matsuda G, Otsuka Y, Ono H, Shimada H. Kunisaki C, et al. J Am Coll Surg. 2005 Jan;200(1):15-9. doi: 10.1016/j.jamcollsurg.2004.09.015. J Am Coll Surg. 2005. PMID: 15631915

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

317 results

Search Page